Summary
The relationships between first-phase insulin secretion to i.v. glucagon and i.v. arginine were studied in 19 healthy adult volunteers (Group I) and in 21 subjects at risk for Type 1 (insulin-dependent) diabetes mellitus with either a “normal” (n=11; Group II a) or a “low” insulin response to i.v. glucose (n=10; Group II b). Groups I and II a displayed similar insulin responses to the three secretagogues. In contrast, Group II b demonstrated lower insulin responses to both glucagon and arginine than control subjects (p}<0.007 and (p}<0.04 respectively) orthan “normo-responders” to glucose (#x007D;<0.007 and p<0.04 respectively). In Group II b however, arginine-stimulated insulin release was increased compared to the response to glucose (p}<0.006), while glucagon and glucose led to non-statistically different responses. Five “low-responders” developed Type 1 diabetes. As a group, they displayed lower responses to glucagon and to arginine than subjects who up to now have not developed the disease (p<0.05 and p<0.0003 respectively). In the subjects who progressed to diabetes, the responses to glucose and glucagon were similarly blunted. In the “low-responders” who have not developed the disease, no statistical difference could be detected between mean responses to glucagon and glucose, but four out of these five subjects had a glucagon-stimulated response within the control range and higher than their corresponding response to glucose. Arginine led to a higher stimulation than glucose, in subgroups that either progressed to diabetes (p<0.006) or did not (p<0.002). Finally, “low-responders” who did not develop diabetes displayed similar responses to both glucagon and arginine than “normo-responders” to glucose. A progressive decrease of arginine-stimulated insulin response may be a later event during pre-Type 1 diabetes than a blunted response to glucose, while a loss of glucagon-stimulated insulin release may be intermediate. Diminished response to all secretagogues may offer better prediction than a “low” response to glucose alone.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Eisenbarth GS (1990) Multiple target antigens in pre type 1 diabetes. Implications for prediction. Horm Res 33: 144–153
Tarn AC, Thomas JM, Dean BM, Ingram D, Schwarz G, Bottazzo GF, Gale EAM (1988) Predicting insulin-dependent diabetes. Lancet 1: 845–850
Bonifacio E, Bingley PJ, Shattock M, Dean BM, Dunger D, Gale EAM, Bottazzo GF (1990) Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 335: 147–149
Baekkeskov S, Landin M, Kristensen JK et al. (1987) Antibodies to a 64000 Mr human islet cell antigen precede the clinical onset of insulin-dependent diabetes. J Clin Invest 79: 926–934
Atkinson MA, McLaren NK, Scharp DW, Lacy PE, Riley WJ (1990) 64 000 Mr autoantibodies as predictors of insulin-dependent diabetes. Lancet 335: 1357–1360
Dean BM, Becker F, McNally JM, Tarn AC, Schwartz G, Gale EAM, Bottazzo GF (1986) Insulin autoantibodies in the prediabetic period: correlation with islet cell antibodies and development of diabetes. Diabetologia 29: 339–342
Ziegler AG, Ziegler R, Vardi P, Jackson RA, Soeldner JS, Eisenbarth GS (1989) Life-table analysis of progression to diabetes of antiinsulin autoantibody-positive relatives of individuals with type 1 diabetes. Diabetes 38: 1320–1325
Bleich D, Jackson RA, Soeldner JS, Eisenbarth GS (1990) Analysis of metabolic progression to type 1 diabetes in ICA+ relatives of patients with type 1 diabetes. Diab Care 13: 111–118
Beer SF, Heaton DA, Alberti KGMM, Pyke DA, Leslie RDG (1990) Impaired glucose tolerance precedes but does not predict insulin-dependent diabetes mellitus: a study in identical twins. Diabetologia 33: 497–502
Srikanta S, Ganda OP, Gleason RE, Jackson RA, Soeldner JS, Eisenbarth GS (1984) Pre type 1 diabetes: linear loss of beta-cell response to intravenous glucose. Diabetes 33: 717–720
McCulloch DK, Raghu PK, Johnston C et al. (1988) Defects in β-cell function and insulin sensitivity in normoglycemic streptozotocin-treated baboons: a model of preclinical insulin-dependent diabetes. J Clin Endocrinol Metab 67: 785–792
Ganda OP, Srikanta S, Brink SJ, Morris MA, Gleason RE, Soeldner JS, Eisenbarth GS (1984) Differential sensitivity to beta-cell secretagogues in “early”, type 1 diabetes mellitus. Diabetes 33: 516–521
Strandell E (1990) Different sensitivity to glucose compared to other beta-cell secretagogues in female NOD mouse islets. Diabetologia 33 [Suppl]: A95 (Abstract)
Tominaga M, Komiya I, Johnson JH et al. (1986) Loss of insulin response to glucose but not arginine during the development of autoimmune diabetes in BB/W rats: relationships to islet volume and glucose transport rate. Proc Natl Acad Sci USA 83: 9749–9753
Heaton DA, Lazarus NR, Pyke DA, Leslie RDG (1989) B-cell response to intravenous glucose and glucagon in non-diabetic twins of patients with Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 32: 814–817
Vialettes B, Mattei-Zevaco C, Badier C, Ramahandridona G, Lassman-Vague V, Vague P (1988) Low acute insulin response to intravenous glucose. A sensitive but non-specific marker of early stages of Type I (insulin-dependent) diabetes. Diabetologia 31: 592–596
Joseph MG, Bardet S, Stetieh H et al. (1990) Age-related changes of acute insulin response to IV glucose (AIRG) in subjects at risk for Type 1 diabetes and progression to diabetes in ICA + IAA + subjects. Diabetologia 33 [Suppl]: A183 (Abstract)
Smith CP, Williams AJK, Thomas JM et al. (1988) The pattern of basal and stimulated insulin responses to intravenous glucose in first-degree relatives of Type 1 (insulin-dependent) diabetic children and unrelated adults aged 5 to 50 years. Diabetologia 31: 430–434
Snorgaard O, Hasselstrom K, Lumholtz IB, Thosteinsson B, Siersbaek-Nielsen K (1988) Insulin/C-peptide response to intravenous glucagon. A dose-response study in normal and noninsulin dependent diabetic subjects. Acta Endocrinol 117: 109–115
Van Haeften TW, Voetberg GA, Gerich JE, Van Der Veen EA (1989) Dose-response characteristics for arginine-stimulated insulin secretion in man and influence of hyperglycemia. J Clin Endocrinol Metab 69: 1059–1064
Palmer JP, Benson JW, Walter RM, Ensinck JW (1976) Argininestimulated acute phase of insulin and glucagon secretion in diabetic subjects. J Clin Invest 58: 565–570
Bardet S, Pasqual C, Maugendre D, Remy JP, Charbonnel B, Sai P (1989) Inter and intra individual variability of acute insulin response during intravenous glucose tolerance tests. Diabète et métabolisme 15: 224–232
Gjessing HJ, Damsgaard EM, Matzen LE, Froland A, Faber OK (1987) Reproducibility of β-cell function estimates in non-insulin-dependent diabetes mellitus. Diab Care 10: 558–562
McCulloch DK, Klaff LJ, Kahn SE et al. (1990) Nonprogression of subclinical β-cell dysfunction among first-degree relatives of IDDM patients. 5-yr follow-up of the Seattle family study. Diabetes 39: 549–556
Bonifacio R, Dawkins RI, Lernmark Å (1987) Report of the second international workshop on the standardization of cytoplasmic islet cell antibodies. Diabetologia 30: 273
Palmer JP, Asplin CM, Clemons P, Lyen K, Tatpati O, Raghu PK, Pacquette TL (1983) Insulin antibodies in insulin dependent diabetics before insulin treatment. Science 222: 1337–1339
Bardet S, Rohmer V, Maugendre D et al. (1990) Beta-cell cytoadherent lymphocytes in some subjects at risk for type 1 (insulin-dependent) diabetes: progression to diabetes within 2 years. J Clin Endocrinol Metab 71: 1310–1317
Lang F, Maugendre D, Houssaint-Chalmeau E, Charbonnel B, Saï P (1987) Cytoadherence of lymphocytes from type 1 diabetics to insulin secreting cells: a marker of anti beta-cell cellular immunity. Diabetes 36: 1356–1364
Johnson JH, Crider BP, McCorkle K, Alford M, Unger RH (1990) Inhibition of glucose transport into rat islet cells by immunoglobulins from patients with new-onset insulin-dependent diabetes mellitus. N Engl J Med 322: 653–659
Orci L, Unger RH, Ravazzola M et al. (1990) Reduced beta-cell glucose transporter in new onset diabetic BB rats. J Clin Invest 86: 1615–1622
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bardet, S., Rohmer, V., Maugendre, D. et al. Acute insulin response to intravenous glucose, glucagon and arginine in some subjects at risk for Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 34, 648–654 (1991). https://doi.org/10.1007/BF00400994
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00400994